|
|
|
|
- The International Focused Ultrasound Society (IFUS) is dedicated to advancing clinical practice and accelerating adoption of focused ultrasound.
- Membership will include clinicians, researchers, and trainees; the focused ultrasound community is encouraged to sign up at no cost for the first year.
|
|
|
|
|
|
|
|
|
|
|
|
- Researchers are now enrolling participants in a clinical trial using focused ultrasound to treat certain types of pancreatic cancer.
- The study at Stanford University is testing the Sonire Therapeutics system in patients with unresectable tumors.
|
|
|
|
|
|
|
|
|
|
|
|
- More than 70 speakers will participate in 28 sessions at the November 11-13 Celebration event, to be held in McLean, Virginia.
- Those listed include researchers, clinicians, patients, industry leaders, and more.
|
|
|
|
|
|
|
|
|
|
|
|
- Laura Lubbers, PhD, chief scientific officer at CURE Epilepsy, shares her top five takeaways from the Foundation’s 2025 Epilepsy Workshop.
- Learn how our organizations are partnering to advance focused ultrasound research and help patients with uncontrollable seizures.
|
|
|
|
|
|
|
|
|
|
|
|
- Stanford researchers developed a noninvasive method of using focused ultrasound to generate light deep inside the body.
- The process enables precise control of biological processes through light-based interventions.
|
|
|
|
|
|
|
|
|
|
|
|
- Professors Gail ter Haar and David Cranston will provide a look back at the history and evolution of focused ultrasound therapy.
- Join us Tuesday, June 9, at 11:00 am Eastern.
|
|
|
|
|
|
|
|
|
|
|
|
- In this episode, Sasha Klibanov, PhD, discusses the evolution of how microbubbles became tools for drug delivery.
- He also explains how focused ultrasound is being combined with microbubbles to treat neurological diseases.
|
|
|
|
|
|
|
|
|
|
“Without the help of the Focused Ultrasound Foundation, this area of research and clinical translation would not be as far ahead as it is now, in my opinion. It is a very important institution in the field.”
‒ Sasha Klibanov, PhD |
|
|
|
|
|
|